Cinven is reviewing strategic options for laboratory-services company Synlab International GmbH including a potential sale, people with knowledge of the matter said.
The private equity firm has been speaking with potential advisers and could start a sale process early next year, the people said, asking not to be identified because the information is private. Cinven plans to seek a valuation of about 5.5 billion euros ($6 billion) including debt for Augsburg, Germany-based Synlab, one of the people said.
A sale of Synlab would likely attract other private equity firms, the people said. No final decision has been made, and Cinven could elect to keep the business, the people said. A spokeswoman for Cinven declined to comment, while Synlab didn’t answer phone calls seeking comment.
Cinven first invested in Synlab in June 2015, buying a majority stake from fellow private equity firm BC Partners for about 1.7 billion euros, Bloomberg News reported at the time. It combined the business with Labco SA, which it agreed to buy earlier that year for 1.2 billion euros.
Synlab, led by Chief Executive Officer Mathieu Floreani, also counts Novo A/S and Ontario Teachers’ Pension Plan as minority investors, according to its website. It operates across more than 40 countries, handling more than 500 million clinical tests annually, according to Synlab’s website.
Cinven also owns stakes in retailer Kurt Geiger and German drugmaker Stada Arzneimittel AG, according to its website.
The sale plan comes at a time when Cinven’s rival Apax Partners is also weighing a sale of diagnostic services business Unilabs. The buyout firm is working with advisers at Rothschild & Co. to look at options for the business, people familiar with the matter said last week.
Source: Bloomberg
Can’t stop reading? Read more
KKR-backed Avida completes debut SRT with Sona to support turnaround plan
KKR-backed Avida completes debut SRT with Sona to support turnaround plan Avida Finans, the Swedish lender owned by KKR, has completed its first significant risk transfer transaction, selling the deal to credit firm Sona Asset Management as it works to strengthen its...
OpenAI strengthens investor alliance with stake in Thrive Holdings
OpenAI strengthens investor alliance with stake in Thrive Holdings OpenAI has acquired a stake in Thrive Holdings, the investment platform launched this year by major OpenAI backer Thrive Capital, in a move designed to accelerate enterprise adoption of artificial...
Axcel reaches €459m hard cap for Elevate Fund I as investors back Nordic lower mid-market strategy
Axcel reaches €459m hard cap for Elevate Fund I as investors back Nordic lower mid-market strategy Axcel has closed Elevate Fund I at its €459m hard cap after strong demand from investors, marking a rapid fundraise that deepens the firm’s reach in the Nordic lower...




